Published in Lancet on February 01, 1997
Acute meningoencephalitis and meningitis due to primary HIV infection. BMJ (2002) 2.52
Molecular diagnosis of herpes simplex virus infections in the central nervous system. J Clin Microbiol (1999) 2.21
Laboratory diagnosis of common viral infections of the central nervous system by using a single multiplex PCR screening assay. J Clin Microbiol (1999) 2.12
Factors influencing PCR detection of viruses in cerebrospinal fluid of patients with suspected CNS infections. J Neurol Neurosurg Psychiatry (2005) 1.82
Comparative evaluation of colorimetric microtiter plate systems for detection of herpes simplex virus in cerebrospinal fluid. J Clin Microbiol (1998) 1.49
Pathology tests: is the time for demand management ripe at last? J Clin Pathol (2003) 1.39
Stable and noncompetitive RNA internal control for routine clinical diagnostic reverse transcription-PCR. J Clin Microbiol (2004) 1.33
Validation of laboratory screening criteria for herpes simplex virus testing of cerebrospinal fluid. J Clin Microbiol (2007) 1.28
PCR in diagnosis of infection: detection of bacteria in cerebrospinal fluids. Clin Diagn Lab Immunol (2002) 1.27
Laboratory diagnosis of common herpesvirus infections of the central nervous system by a multiplex PCR assay. J Clin Microbiol (2001) 1.23
Borna disease virus infection in animals and humans. Emerg Infect Dis (1997) 1.07
Molecular approaches to detecting herpes simplex virus and enteroviruses in the central nervous system. J Clin Microbiol (2002) 1.04
Role of IS6110-targeted PCR, culture, biochemical, clinical, and immunological criteria for diagnosis of tuberculous meningitis. J Clin Microbiol (2000) 1.04
PCR for diagnosis of viral infections of the central nervous system. Lancet (1997) 0.98
Criteria for reducing unnecessary testing for herpes simplex virus, varicella-zoster virus, cytomegalovirus, and enterovirus in cerebrospinal fluid samples from adults. J Clin Microbiol (2015) 0.88
Molecular Techniques in the Diagnosis of Central Nervous System Infections. Curr Infect Dis Rep (2002) 0.87
Usefulness of Herpes Consensus PCR methodology to routine diagnostic testing for herpesviruses infections in clinical specimens. Virol J (2007) 0.85
A case of ramsay hunt syndrome complicated by cerebellitis. J Clin Neurol (2006) 0.79
Molecular techniques for clinical diagnostic virology. J Clin Pathol (2000) 0.77
Acute childhood encephalitis and meningoencephalitis: Diagnosis and management. Paediatr Child Health (1998) 0.76
Elsberg syndrome: A rarely recognized cause of cauda equina syndrome and lower thoracic myelitis. Neurol Neuroimmunol Neuroinflamm (2017) 0.75
Herpes zoster and aseptic meningitis in a previously healthy child. Eur J Pediatr (2003) 0.75
Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature (1991) 10.85
Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci U S A (1997) 8.05
Tempting fate: control of communicable disease in England. BMJ (1993) 5.62
A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med (1996) 4.64
Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group. J Clin Microbiol (1998) 4.07
Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature (1995) 3.61
Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Lancet (1992) 3.60
Population dynamics of immune responses to persistent viruses. Science (1996) 3.49
Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol (1998) 3.32
High incidence of malaria in alpha-thalassaemic children. Nature (1996) 3.12
Absence of malaria-specific mortality in children in an area of hyperendemic malaria. Trans R Soc Trop Med Hyg (1998) 3.09
Demand incidence and episode rates of ophthalmic disease in a defined urban population. BMJ (1992) 2.96
Adult attachment, working models, and relationship quality in dating couples. J Pers Soc Psychol (1990) 2.94
Strategies for the prevention of malaria in travellers: comparison of drug regimens by means of risk-benefit analysis. Lancet (1986) 2.88
Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T. Lancet (1994) 2.78
Aseptic meningitis and encephalitis: the role of PCR in the diagnostic laboratory. J Clin Microbiol (1997) 2.76
Rubella antibody tests in family planning clinics. Practitioner (1976) 2.64
HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A (1999) 2.45
Comparison between the weekly returns service and the Oxford regional sentinel practice scheme for monitoring communicable diseases. J R Coll Gen Pract (1988) 2.32
The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis (1995) 2.31
Runway malaria. Lancet (1990) 2.30
Analysis of the human alpha-globin gene cluster reveals a highly informative genetic locus. Proc Natl Acad Sci U S A (1986) 2.26
An outbreak of waterborne cryptosporidiosis in Swindon and Oxfordshire. Epidemiol Infect (1991) 2.21
Urinary tract in schoolgirls with covert bacteriuria. Arch Dis Child (1975) 2.21
alpha+-Thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci U S A (1997) 2.19
Selection forces and constraints on retroviral sequence variation. Science (2001) 2.17
Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants. J Immunol (1986) 2.13
The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu. Trans R Soc Trop Med Hyg (1997) 2.12
Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet (1986) 2.04
Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule. Arch Dis Child (1992) 2.02
Haemophilus influenzae type b disease in the Oxford region. Arch Dis Child (1989) 1.95
Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology (1992) 1.94
Cytotoxic T-cell response to respiratory syncytial virus in mice. J Virol (1985) 1.92
Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood (2000) 1.87
The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-alpha and MMP13. Osteoarthritis Cartilage (2008) 1.81
Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet (1987) 1.80
The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol (2000) 1.73
The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models. J Neurosci Methods (2000) 1.70
Long-term persistence of activated cytotoxic T lymphocytes after viral infection of the central nervous system. J Exp Med (1998) 1.68
Acute herpes hepatitis in pregnancy. J Clin Pathol (1993) 1.60
The incidence of GBS disease in neonates in different countries. Antibiot Chemother (1971) (1985) 1.57
Efficacy of Haemophilus influenzae type B conjugate vaccine in Oxford region. Lancet (1992) 1.55
The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J Virol (1994) 1.46
Invasive Haemophilus influenzae type b disease in the Oxford region (1985-91). Arch Dis Child (1993) 1.42
Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations. Sri Lanka Thalassaemia Study Group. Lancet (2000) 1.42
Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom. Arch Dis Child (1989) 1.42
Invasive pneumococcal disease in England and Wales: vaccination implications. J Infect Dis (2000) 1.42
Prevention of cerebral malaria in children in Papua New Guinea by southeast Asian ovalocytosis band 3. Am J Trop Med Hyg (1999) 1.36
Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity (2000) 1.34
Changing patterns of communicable disease in England and Wales: part II-Disappearing and declining diseases. Br Med J (1980) 1.30
Present versus future time perspective and HIV risk among heterosexual college students. Health Psychol (1996) 1.27
Do infectious diseases drive MHC diversity? Microbes Infect (2000) 1.26
Cycles, chaos, and evolution in virus cultures: a model of defective interfering particles. Proc Natl Acad Sci U S A (1994) 1.24
Plasmodium vivax: a cause of malnutrition in young children. QJM (1997) 1.23
Epidemiological studies of large resistance plasmids in Haemophilus. J Antimicrob Chemother (2000) 1.22
Diphtheria, pertussis, and tetanus vaccination. Lancet (1992) 1.21
The immunogenicity of intracerebral virus infection depends on anatomical site. J Virol (1997) 1.19
Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1. Proc Biol Sci (2001) 1.19
Meningitis and endophthalmitis caused by Streptococcus suis type II (group R). Br Med J (1977) 1.19
Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria. J Antimicrob Chemother (1995) 1.18
Deferoxamine inhibition of malaria is independent of host iron status. J Exp Med (1988) 1.17
Challenges faced by health workers in implementing the prevention of mother-to-child HIV transmission (PMTCT) programme in Uganda. J Public Health (Oxf) (2007) 1.17
Adverse effects of antimalarials. An update. Drug Saf (1993) 1.16
The incidence of scarlet fever. J Hyg (Lond) (1983) 1.15
Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax. J Virol (1995) 1.15
High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis. Virology (1996) 1.14
A study of 42 episodes of overwhelming post-splenectomy infection: is current guidance for asplenic individuals being followed? J Infect (1997) 1.14
The dynamics of HTLV-I and the CTL response. Immunol Today (1999) 1.14
Why type streptococci? The epidemiology of group A streptococci in Oxfordshire 1976-1980. J Hyg (Lond) (1982) 1.14
Iron and infection. Br Med J (Clin Res Ed) (1988) 1.12
Allele-specific DNA identity patterns. Hum Genet (1987) 1.11
Prospective study of HTLV-I infection in an initially asymptomatic cohort. J Acquir Immune Defic Syndr (1999) 1.09
High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells. Blood (2001) 1.09
Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus. Proc Natl Acad Sci U S A (1986) 1.09
Acute transverse myelitis after tetanus toxoid vaccination. Lancet (1992) 1.07
Iron overload in mild sideroblastic anaemias. Lancet (1983) 1.06
Red blood cell phenotypes in the alpha + thalassaemias from early childhood to maturity. Br J Haematol (1996) 1.06
Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells. J Infect Dis (1994) 1.06
A reappraisal of the effects of iron and desferrioxamine on the growth of Plasmodium falciparum 'in vitro': the unimportance of serum iron. Br J Haematol (1986) 1.05
Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm. Neurology (2003) 1.05
The impact of HIV on maternal quality of life in Uganda. AIDS Care (2006) 1.04
Multiple origins of the sickle mutation: evidence from beta S globin gene cluster polymorphisms. Mol Biol Med (1983) 1.04
"Boil the water". Lancet (1989) 1.03
Treatment of bacteriuria in shcoolgirls. Kidney Int Suppl (1975) 1.02
Immune and inflammatory responses to stroke: good or bad? Int J Stroke (2008) 1.00
The effect of a policy of non-vaccination of schoolchildren on the incidence of tuberculosis in Oxfordshire. J Public Health Med (1991) 0.99
Familial polycystic ovaries: a genetic disease? Clin Endocrinol (Oxf) (1988) 0.98
Protection against lethal influenza virus encephalitis by intranasally primed CD8+ memory T cells. J Immunol (1996) 0.97
Plasticizers increase adhesion of the deteriogenic fungus Aureobasidium pullulans to polyvinyl chloride. Appl Environ Microbiol (1999) 0.96
Post-partum rubella immunisation: a controlled trial of two vaccines. Lancet (1983) 0.96
High frequency of viral protein expression in human T cell lymphotropic virus type 1-infected peripheral blood mononuclear cells. AIDS Res Hum Retroviruses (2000) 0.96
An outbreak of tuberculosis in an Oxfordshire school. Br J Dis Chest (1987) 0.95
How should another Camelford be managed? BMJ (1993) 0.95
Group B streptococcal systemic disease in Great Britain. J Infect (1981) 0.95
Virus dissemination through the brain parenchyma without immunologic control. J Immunol (1997) 0.94
The antimalarial effect of iron chelators: studies in animal models and in humans with mild falciparum malaria. J Inorg Biochem (1992) 0.94
Plasma-derived versus recombinant hepatitis B vaccines. Lancet (1989) 0.93